Inflammation and Parkinson's disease pathogenesis
Identifieur interne : 003724 ( Istex/Curation ); précédent : 003723; suivant : 003725Inflammation and Parkinson's disease pathogenesis
Auteurs : Serge Przedborski [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2010.
English descriptors
- KwdEn :
Abstract
Inflammation is a neuropathological feature of parkinsonian brains and also in experimental models of the disease. It is believed that activated glial cells, which compose the majority of this inflammatory response contribute to the neurodegenerative process through the production of toxic molecules. Therapeutic strategies geared toward reducing inflammation and inhibiting the production of these glial‐derived toxic molecules may be a promising neuroprotective strategy for the treatment of Parkinson's disease and related conditions. © 2010 Movement Disorder Society
Url:
DOI: 10.1002/mds.22638
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003724
Links to Exploration step
ISTEX:E9EFAE6C04F827D7F710F0D12104E4DD2321437CLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inflammation and Parkinson's disease pathogenesis</title><author><name sortKey="Przedborski, Serge" sort="Przedborski, Serge" uniqKey="Przedborski S" first="Serge" last="Przedborski">Serge Przedborski</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Pathology and Cell Biology, Columbia University, New York, New York, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Pathology and Cell Biology, Columbia University, New York, New York</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E9EFAE6C04F827D7F710F0D12104E4DD2321437C</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1002/mds.22638</idno><idno type="url">https://api.istex.fr/document/E9EFAE6C04F827D7F710F0D12104E4DD2321437C/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003724</idno><idno type="wicri:Area/Istex/Curation">003724</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Inflammation and Parkinson's disease pathogenesis</title><author><name sortKey="Przedborski, Serge" sort="Przedborski, Serge" uniqKey="Przedborski S" first="Serge" last="Przedborski">Serge Przedborski</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Pathology and Cell Biology, Columbia University, New York, New York, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Pathology and Cell Biology, Columbia University, New York, New York</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010">2010</date><biblScope unit="vol">25</biblScope><biblScope unit="issue">S1</biblScope><biblScope unit="page" from="S55">S55</biblScope><biblScope unit="page" to="S57">S57</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">E9EFAE6C04F827D7F710F0D12104E4DD2321437C</idno><idno type="DOI">10.1002/mds.22638</idno><idno type="ArticleID">MDS22638</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>MPTP</term><term>Parkinson's disease</term><term>inflammation</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Inflammation is a neuropathological feature of parkinsonian brains and also in experimental models of the disease. It is believed that activated glial cells, which compose the majority of this inflammatory response contribute to the neurodegenerative process through the production of toxic molecules. Therapeutic strategies geared toward reducing inflammation and inhibiting the production of these glial‐derived toxic molecules may be a promising neuroprotective strategy for the treatment of Parkinson's disease and related conditions. © 2010 Movement Disorder Society</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003724 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 003724 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:E9EFAE6C04F827D7F710F0D12104E4DD2321437C
|texte= Inflammation and Parkinson's disease pathogenesis
}}
| This area was generated with Dilib version V0.6.23. |  |